UK Puts Wegovy on NHS to Guard Obese Adults Against Heart Problems
Prime Highlights: NICE recommended Wegovy for NHS use, making it the first GLP-1 drug cleared to reduce heart attack and
Slovak Researcher Gains European Certification in Obesity Care
Prime Highlights: A researcher from the Slovak Academy of Sciences has secured European certification, marking progress in tackling major health
EHA Launches Platform to Boost Europe’s Healthcare Collaboration
Prime Highlights: European Healthcare Alliance launches a digital platform to boost collaboration across the sector. Initiative aims to unlock new
Axarquia’s 1980s Hospital Gets a Long-Overdue Upgrade
Prime Highlights: Andalucian President Juanma Moreno inaugurated the expanded Hospital Comarcal de la Axarquia in Velez-Malaga after a €4 million
Global Bodies Join Forces to Strengthen Public Health Cooperation in Europe and Central Asia
Prime Highlights: The event brings together global organisations to improve cooperation under the One Health approach. It focuses on teamwork
EU Study Highlights Impact of AI on Healthcare Transformation
Prime Highlights: European Commission study highlights growing role of AI in transforming healthcare across Europe. Digital health technologies are expected
New Blood Test Offers Hope for Early Glioblastoma Diagnosis
Prime Highlights : A new blood test shows promise in detecting glioblastoma using specific protein markers. The test could offer
NHS Trial Tests New Non-invasive Method to Diagnose Endometriosis Earlier
Prime Highlights: A new clinical trial led by Worcestershire Acute NHS Trust is testing a non-invasive method to diagnose Endometriosis
Women Scientists Lead Breakthrough Health Innovations Across Europe
Prime Highlights: Women scientists across Europe are driving important breakthroughs in healthcare and biotechnology, including advancements in breast cancer testing
European Commission Approves Four-Week Dosing for Fabry Disease Therapy
Prime Highlights: European Commission approves a new four-week dosing schedule for pegunigalsidase alfa. The revised schedule reduces hospital visits, easing